Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

By Application

Nuclear Bodies

Creative Biolabs provides a range comprehensive of recombinant antibodies used in the research of nuclear bodies.

Nuclear bodies (also known as Nuclear dots, nuclear domains, or PML bodies) are punctate structures found in the nuclei of certain cells. Simple nuclear bodies (types I and II) and the shells of complex NB (types III, IVa and V) are composed of a non-chromatinic fibrillar material which is most likely proteinaceous.